22550-27-2Relevant academic research and scientific papers
A convenient, efficient and reusable N-heterocyclic carbene-palladium(II) based catalyst supported on magnetite for Suzuki-Miyaura and Mizoroki-Heck cross-coupling reactions
Kandathil, Vishal,Fahlman, Bradley D.,Sasidhar,Patil, Siddappa A.,Patil, Shivaputra A.
, p. 9531 - 9545 (2017/08/29)
In the present work, a new magnetic nanoparticle supported N-heterocyclic carbene-palladium(ii) (NO2-NHC-Pd@Fe3O4) nanomagnetic catalyst was synthesized by a facile multistep synthesis under aerobic conditions using inexpensive chemicals. The NO2-NHC-Pd@Fe3O4 nanomagnetic catalyst was characterized by various analytical techniques such as attenuated total reflectance infrared spectroscopy (ATR-IR), inductively coupled plasma-atomic emission spectroscopy (ICP-AES), energy-dispersive X-ray spectroscopy (EDS), field-emission scanning electron microscopy (FESEM), transmission electron microscopy (TEM), X-ray powder diffraction (XRD), thermogravimetric analysis (TGA) and Brunauer-Emmett-Teller surface area analysis (BET). The synthesized NO2-NHC-Pd@Fe3O4 nanomagnetic catalyst showed excellent catalytic activity in both Suzuki-Miyaura and Mizoroki-Heck cross-coupling reactions for various substrates under mild reaction conditions. Recovery of the NO2-NHC-Pd@Fe3O4 nanomagnetic catalyst from the reaction mixture was easily accomplished by applying an external magnet. The recovered NO2-NHC-Pd@Fe3O4 nanomagnetic catalyst exhibited very good catalytic activity up to seven recycles in Suzuki-Miyaura and five recycles in Mizoroki-Heck cross-coupling reactions without considerable loss of its catalytic activity.
4-PHENYLAMINO-PYRIMIDINE DERIVATIVES HAVING PROTEIN KINASE INHIBITOR ACTIVITY
-
Page/Page column 34-35, (2011/07/09)
The invention relates compounds of general formula (I) and pharmaceutically acceptable salts and solvates thereof wherein R1 is halogen, vinylene-aryl, substituted aryl, heteroaryl or a benzo[1,3]dioxolil group, W is a group of formula -NH-SO2-R2 or heteroaryl group or NHR3 group where R3 is hydrogen or heteroaryl; and n is 1, 2, 3 or 4. Furthermore, the present invention is directed to pharmaceutical composition containing at least one compound of general formula (I) and/or pharmaceutically acceptable salts or solvates thereof and for the use of them for the preparation of pharmaceutical compositions for the prophylaxis and/or the treatment of protein kinase related, especially CDK9-related diseases e.g. cell proliferative disease, infectious disease, pain, cardiovascular disease and inflammation.
Bergman cycloaromatization of imidazole-fused enediynes: The remarkable effect of N-aryl substitution
Zhao, Zhengrong,Peng, Yunshan,Dalley, N. Kent,Cannon, John F.,Peterson, Matt A.
, p. 3621 - 3624 (2007/10/03)
A series of N-aryl substituted 'imidazole-fused' (Z) 3-ene-1,5-diynes was prepared and kinetic parameters for their Bergman cycloaromatization reactivities were determined. N-Arylation enhanced rates relative to N-alkyl derivatives by up to sevenfold (ANOVA p0.0001). The greatest enhancement was exhibited by the N-phenyl derivative (sevenfold at 145°C).
Structure-activity studies on a 1,2,3-triazole derivative, a potent in vitro inhibitor of prostaglandin synthesis: The role of the heterocyclic ring
Biagi,Dell'Omodarme,Ferretti,Giorgi,Livi,Scartoni
, p. 335 - 344 (2007/10/02)
This paper reports further structural modifications concerning the 1,2,3- triazole ring of the compound A, an effective in vitro inhibitor of prostaglandin synthesis. The introduction of different heterocyclic rings provided further information about of t
SUBSTITUTION NUCLEOPHYLE RADICALAIRE EN CHAINE (SRN1). 16eme MEMOIRE: N-ALCOYLATION DE L'IMIDAZOLE, DU BENZIMIDAZOLE, DU PYRRAZOLE ET DU TRIAZOLE
Beugelmans, Rene,Lechevalier, Andre
, p. 6209 - 6212 (2007/10/02)
The title amines behave as nucleophiles towards p-nitrobenzylchloride or variously funtionnalyzed gem-halo nitro alkanes in reactions responding to the classical criteria for the SRN1 mechanism.
